Proximal duodenal perforation in three dogs following deracoxib administration

Journal of the American Animal Hospital Association

Volumn 46, Issue 4, 2010, Pages 255-258

  Case, J Brad ^a,b   Fick, Jennifer L ^a,b   Rooney, Matthew B ^a,b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DERACOXIB; PROSTAGLANDIN SYNTHASE INHIBITOR; SULFONAMIDE;

ANIMAL; CASE REPORT; CHEMICALLY INDUCED; COMPLICATION; DOG; DOG DISEASES; DUODENAL DISEASES; FATALITY; INTESTINAL PERFORATION; MALE; PERITONITIS; TREATMENT OUTCOME; VETERINARY;

ANIMALS; CYCLOOXYGENASE INHIBITORS; DOG DISEASES; DOGS; DUODENAL DISEASES; FATAL OUTCOME; INTESTINAL PERFORATION; MALE; PERITONITIS; SULFONAMIDES; TREATMENT OUTCOME;

EID: 77956283208     PISSN: 15473317     EISSN: 15473317     Source Type: Journal    
DOI: 10.5326/0460255     Document Type: Article

References (14)

1. Budsberg SC. Nonsteroidal anti-inflammatory drugs. In: Gaynor JS, Muir WW, eds. Handbook of Veterinary Pain Management. Philadelphia: Mosby Inc., 2002:184-198.
2. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol 1971;231:232-235.
3. Miller TA. Gastroduodenal mucosal defense: factors responsible for the ability of the stomach and duodenum to resist injury. Surgery 1988;103:389-397.
4. Gana TJ. Focal gastric mucosal blood flow in aspirin-induced ulceration. Ann Surg 1987;205:399-403.
5. Jones RD, Baynes RE, Nimitz CT. Nonsteroidal anti-inflammatory drug toxicosis in dogs and cats: 240 cases (1989-1990). J Am Vet Med Assoc 1992;201:475-477.
6. Reimer ME. The gastroduodenal effects of buffered aspirin, carprofen, and etodolac in healthy dogs. J Vet Intern Med 1999;13:472-477.
7. Bergh MS, Budsberg SC. The coxib NSAID: potential clinical and pharmacological importance in veterinary medicine. J Vet Intern Med 2005;19:633-643.
8. Luna SPL, Basilio AC. Evaluation of adverse effects of long-term oral administration of carprofen, etodolac, flunixin meglumine, ketoprofen, and meloxicam in dogs. Am J Vet Res 2007;68:258-264.
9. Lascelles BD, Blikslager AT, Fox SM, et al. Gastrointestinal tract perforation in dogs treated with a selective cyclooxygenase-2 inhibitor: 29 cases (2002-2003). J Am Vet Med Assoc 2005;227:1112-1117.
10. Stanton ME, Bright RM. Gastroduodenal ulceration in dogs. Retrospective study of 43 cases and literature review. J Vet Intern Med 1989;3:238-244.
11. Hinton LE, McLoughlin MA, Johnson SE, et al. Spontaneous gastroduodenal perforation in 16 dogs and seven cats (1982-1999). J Am Anim Hosp Assoc 2002;38:176-187.
12. Schneider HT, Nuernberg B, Dietzel K, et al. Biliary elimination of non-steroidal anti-inflammatory drugs in patients. Br J Clin Pharmac 1990;29:127-131.
13. Treinen-Molsen M, Kanz MF. Intestinal tract injury by drugs: importance of metabolite delivery by yellow bile road. Pharmacology & Therapeutics 2006;112:649-667.
14. Seitz S, Boelsterli UA. Diclofenac acyl glucuronide, a major biliary metabolite, is directly involved in small intestinal injury in rats. Gastroenterology 1998;115:1476-1482.